Unplanned life events sidelined University of Arkansas for Medical Sciences (UAMS) researcher Chenghui Li, Ph.D., for two years, but since returning in 2020 she has authored or co-authored 33 published papers, thanks largely to a National Center for Advancing Translational Sciences (NCATS) re-entry grant.
The NCATS re-entry grants, also known as the Clinical and Translational Science Award (CTSA) Program Diversity, Re-training, Re-integration, and Re-entry Supplement, support researchers trying to resume their careers after time away. Dr. Li received the two-year $221,000 grant to support her research into if and why many breast cancer patients in Arkansas are not receiving or adhering to a potentially life-saving hormone treatment known as endocrine therapy.
Read the full article here.
